MLAB 株価分析 — MESA LABORATORIES INC (Technology >> Scientific & Technical Instruments)
MLAB に関するよくある質問
MLABのPER(株価収益率)は?
MESA LABORATORIES INC(MLAB)は現在PER 51.52倍で取引されています。
MLABのROE(自己資本利益率)は?
MESA LABORATORIES INCのROEは3.60%です。
MLABの配当利回りは?
MESA LABORATORIES INCの配当利回りは0.64%です。
MLABの品質スコア(Quality Score)は?
当社のAIはMLABの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
MLABは今が買い時ですか?
当社AIのタイミングスコアは100点中89点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
MLABはどのセクターに属しますか?
MESA LABORATORIES INCはTechnology >> Scientific & Technical Instrumentsセクターに分類されます(NASDAQ市場)
MLAB AI Analysis Summary
Our AI summary for MLAB: MESA LABORATORIES INC (NASDAQ), Technology >> Scientific & Technical Instruments sector. The stock currently trades at a P/E of 51.52, ROE of 3.60%, a dividend yield of 0.64%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 100.81
Price
-0.23
(-0.23%)
Day Change
|
|
|---|
MLAB, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) but テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 100.81 |
| PBV / Sector |
3.00 / 3.88
|
| Earning Per Share | 1.21 |
| PE / Sector |
51.52 / 44.83
|
| PEG or PE/Growth / Sector |
N/A / -2.56
|
| Average 1M Daily Value |
16.03 M
GREAT
|
| Average 1W Daily Value |
10.59 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
58% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
41% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:10 |
| Symbol | MLAB |
| Name | MESA LABORATORIES INC |
| Sector | Technology >> Scientific & Technical Instruments |
| Market | NASDAQ |
| Listed Shares | 5.52 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 558.89 / 12,578.27 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 12100 West Sixth Avenue, Lakewood, CO, United States, 80228
Phone: 303 987 8000
Website: https://www.mesalabs.com
Employees: 717
Description: Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Analyst Ratings & Target Price
ME vs SECTOR Technology >> Scientific & Technical Instruments
Click a bubble to view stock details · Bubble size represents market capitalization share
Google